4890 SB
Generic Name: ropinirole
Pill imprint 4890 SB has been identified as Requip 0.25 mg.
Requip is used in the treatment of restless legs syndrome; parkinson's disease; periodic limb movement disorder and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy.
Requip 0.25 mg is not subject to the Controlled Substances Act.
See also related documents.
Requip Images
- Generic Name:
- ropinirole
- Imprint:
-
4890
SB - Strength:
- 0.25 mg
- Color:
- White
- Size:
- 8.00 mm
- Shape:
- Five-sided
- Availability:
- Prescription only
- Inactive Ingredients:
- croscarmellose sodium
lactose monohydrate
magnesium stearate
microcrystalline cellulose
hypromellose 2910 (3 mPa.s)
polyethylene glycol 400
polysorbate 80
titanium dioxide
- Drug Class:
- Dopaminergic antiparkinsonism agents
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- GlaxoSmithKline
- National Drug Code (NDC):
- 00007-4890
| NDC Code | Manufacturer / Repackager |
|---|---|
| 54868-4213 | Physicians Total Care Inc (repackager) |
| 68387-0198 | Keltman Pharmaceuticals Inc (repackager) |
| 35356-0522 | Lake Erie Medical and Surgical Supply (repackager) |
Note: Inactive ingredients may vary.
Advertisement
More Requip resources
Search Again
